Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Theravance Biopharma

17.03
+0.01500.09%
Volume:99.26K
Turnover:1.69M
Market Cap:882.38M
PE:16.29
High:17.05
Open:17.01
Low:17.01
Close:17.01
52wk High:21.03
52wk Low:13.08
Shares:51.83M
Float Shares:25.86M
Volume Ratio:0.48
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.05
EPS(LYR):2.06
ROE:20.91%
ROA:1.33%
PB:3.05
PE(LYR):8.26

Loading ...

OverviewCompanyNewsFilings

Theravance Biopharma Price Target Maintained With a $21.00/Share by BTIG

Dow Jones
·
Mar 20

Theravance Biopharma investors face litigation after 26% stock plunge

Reuters
·
Mar 19

Ireland's Theravance Biopharma Q4 revenue misses expectations

Reuters
·
Mar 19

Theravance Biopharma Q4 Operating Income USD 20.012 Million

Reuters
·
Mar 19

Theravance Biopharma Q4 EPS $1.15 Beats $1.02 Estimate, Sales $45.891M Miss $50.793M Estimate

Benzinga Earnings
·
Mar 19

Theravance Biopharma reports Q4 EPS $1.15, consensus $1.10

TIPRANKS
·
Mar 19

Theravance Biopharma Q4 EPS USD 1.15

THOMSON REUTERS
·
Mar 19

Corrected-Theravance Biopharma Q4 Revenue USD 45.9 Million VS. Ibes Estimate USD 58.5 Million (Corrects Amount)

THOMSON REUTERS
·
Mar 19

Theravance Biopharma Q4 Adjusted Net Income USD 3.131 Million VS. Ibes Estimate USD 58.3 Million

THOMSON REUTERS
·
Mar 19

Corrected-Theravance Biopharma Q4 Adjusted Net Income USD 3.131 Million (Removes Reference to Estimate)

THOMSON REUTERS
·
Mar 19

Theravance Biopharma SVP, Comm & Medical Affairs Rhonda Farnum disposes of USD 432,167 in common shares

Reuters
·
Mar 19

Analyst Rate

Hold
Buy
20.00%
Hold
80.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 10, 2026 Pre-MKt
Financial Report Announcement
May 07, 2026 Pre-MKt
Financial Report Announcement
Mar 19, 2026 Pre-MKt
Financial Report Announcement
Mar 03, 2026 Pre-MKt
Financial Report Announcement
Nov 10, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

16.29
Current
1.88
Sector Average
86.91%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
16.29
Maximum
57.47
+1 STD
18.02
Minimum
-11.13
-1 STD
-14.26
Average
1.88

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.